{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-09",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "66993-782",
      "generic_name": "phentermine and topiramate",
      "labeler_name": "Prasco Laboratories",
      "dea_schedule": "CIV",
      "brand_name": "phentermine and topiramate",
      "active_ingredients": [
        {
          "name": "PHENTERMINE HYDROCHLORIDE",
          "strength": "11.25 mg/1"
        },
        {
          "name": "TOPIRAMATE",
          "strength": "69 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "66993-782-30",
          "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (66993-782-30)",
          "marketing_start_date": "20250601",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Prasco Laboratories"
        ],
        "rxcui": [
          "1302827",
          "1302839",
          "1302850",
          "1313059"
        ],
        "spl_set_id": [
          "876bd763-13fa-481e-b579-c2fc44dbf3c2"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0366993783307",
          "0366993782300",
          "0366993781303",
          "0366993780306"
        ],
        "nui": [
          "N0000008486",
          "N0000185506",
          "N0000182140"
        ],
        "pharm_class_pe": [
          "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
        ],
        "pharm_class_moa": [
          "Cytochrome P450 3A4 Inducers [MoA]",
          "Cytochrome P450 2C19 Inhibitors [MoA]"
        ],
        "unii": [
          "0K2I505OTV",
          "0H73WJJ391"
        ]
      },
      "marketing_category": "NDA AUTHORIZED GENERIC",
      "dosage_form": "CAPSULE, EXTENDED RELEASE",
      "spl_id": "52217277-c719-2f2f-e063-6394a90a6699",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20250601",
      "product_id": "66993-782_52217277-c719-2f2f-e063-6394a90a6699",
      "application_number": "NDA022580",
      "brand_name_base": "phentermine and topiramate",
      "pharm_class": [
        "Appetite Suppression [PE]",
        "Cytochrome P450 2C19 Inhibitors [MoA]",
        "Cytochrome P450 3A4 Inducers [MoA]",
        "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
        "Increased Sympathetic Activity [PE]",
        "Sympathomimetic Amine Anorectic [EPC]"
      ]
    }
  ]
}